Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04770207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Primary completion date: Nov 1, 2025 to Nov 1, 2029
    • Study completion date: Nov 1, 2028 to Nov 1, 2035
    v6
  3. Interventions: Injection of drug-eluting microspheres into malignant tumors (Drug) to Injection of drug-eluting microspheres with multiple drugs into solid tumors (Drug)
    • Study description revised
    • Study arms: 1 to 3
    • Study title expanded, about 3 words
    v5
  4. Study description expanded, about 36 wordsv4
  5. Primary completion date: Nov 1, 2022 to Nov 1, 2025
    • Study completion date: Nov 1, 2023 to Nov 1, 2028
    v3
  6. Phase: Phase 4 to Phase 2v2 Show 8 more changesShow less
    • Enrollment target: 1 to 100
    • Primary completion date: Nov 1, 2021 to Nov 1, 2022
    • Primary endpoint revised
    • Study completion date: Nov 1, 2022 to Nov 1, 2023
    • Study description shortened, about 6 words
    • Site details revised
    • Eligibility criteria expanded, about 1 word
    • Study title shortened, about 2 words
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Trial Details
NCT Number NCT04770207
Lead Sponsor Second Affiliated Hospital of Guangzhou Medical University
Conditions
(from sponsor)		 Hepatocellular Carcinoma, Solid Tumor, Adult
Related terms Carcinoma, Hepatocellular, Lung Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov